Abstract:Acute disseminated encephalomyelitis in children is not uncommon in developing countries, yet there is little systematic documentation of its clinical profile and follow-up. We studied the clinical and neuroradiologic features of acute disseminated encephalomyelitis in 52 consecutive children. Clinical details, magnetic resonance imaging (MRI) findings, and the results of other investigations were recorded, and children were followed up from 6 to 48 months. A repeat MRI was done after 3 to 4 months, and in tho… Show more
“…[245816] One difference noticed was the absence of optic neuritis in the present sample. Optic neuritis is reported to occur in 3-35% of cases in various reports.…”
Section: Discussionmentioning
confidence: 80%
“…Studies from India and abroad have reported that ADEM is more common in boys,[2–489] while multiple sclerosis, the other demyelinating disorder with many similarities, is more common in women. [1011] The reason for this female preponderance in the present sample should be evaluated in view of the disproportionate increase in the incidence of multiple sclerosis in women in recent studies.…”
Aim:To study the clinical profile of acute disseminated encephalomyelitis (ADEM) in children.Materials and Methods:All children admitted with ADEM during a period of one and a half years were included in the study. The diagnosis of ADEM was made based on the clinical presentation and suggestive MRI findings. All children were treated with intravenous methyl prednisolone, followed by oral prednisolone and followed up for varying periods up to three and a half years.Results:The sample consisted of 14 children with 11(79%) girls and 3 (21%) boys. The oldest child was 12 years and the youngest was a six-month-old infant. Acute febrile illness preceded the onset of neurological symptoms in 64% of children. The interval between the preceding illness and symptoms of ADEM varied from 7 days to 28 days (mean 12 days). The common presenting symptoms were fever, vomiting, headache, gait disturbance and generalized seizures. Neurological manifestations included altered sensorium, multiple cranial nerve involvement, quadriplegia and paraplegia, dystonia and choreiform movements, nystagmus, bladder involvement (both incontinence and retention), speech defect and double vision. Facial nerve was the most common cranial nerve involved. Psychological manifestations included aggressive behavior, psychotic symptoms and mood changes. One child each had features of acute psychotic episode and depressive episode. All children recovered fully. One child had multiphasic disseminated encephalomyelitis (MDEM) on follow up.Conclusion:Despite the serious neuropsychiatric manifestations, ADEM in children generally has good immediate outcome. Children with ADEM need long-term follow up for cognitive impairments.
“…[245816] One difference noticed was the absence of optic neuritis in the present sample. Optic neuritis is reported to occur in 3-35% of cases in various reports.…”
Section: Discussionmentioning
confidence: 80%
“…Studies from India and abroad have reported that ADEM is more common in boys,[2–489] while multiple sclerosis, the other demyelinating disorder with many similarities, is more common in women. [1011] The reason for this female preponderance in the present sample should be evaluated in view of the disproportionate increase in the incidence of multiple sclerosis in women in recent studies.…”
Aim:To study the clinical profile of acute disseminated encephalomyelitis (ADEM) in children.Materials and Methods:All children admitted with ADEM during a period of one and a half years were included in the study. The diagnosis of ADEM was made based on the clinical presentation and suggestive MRI findings. All children were treated with intravenous methyl prednisolone, followed by oral prednisolone and followed up for varying periods up to three and a half years.Results:The sample consisted of 14 children with 11(79%) girls and 3 (21%) boys. The oldest child was 12 years and the youngest was a six-month-old infant. Acute febrile illness preceded the onset of neurological symptoms in 64% of children. The interval between the preceding illness and symptoms of ADEM varied from 7 days to 28 days (mean 12 days). The common presenting symptoms were fever, vomiting, headache, gait disturbance and generalized seizures. Neurological manifestations included altered sensorium, multiple cranial nerve involvement, quadriplegia and paraplegia, dystonia and choreiform movements, nystagmus, bladder involvement (both incontinence and retention), speech defect and double vision. Facial nerve was the most common cranial nerve involved. Psychological manifestations included aggressive behavior, psychotic symptoms and mood changes. One child each had features of acute psychotic episode and depressive episode. All children recovered fully. One child had multiphasic disseminated encephalomyelitis (MDEM) on follow up.Conclusion:Despite the serious neuropsychiatric manifestations, ADEM in children generally has good immediate outcome. Children with ADEM need long-term follow up for cognitive impairments.
“…It is characteristically monophasic and, when present, impaired consciousness is a helpful feature to help discriminate it from other demyelinating diseases such as MS. CC and other periventricular lesions in ADEM may be less common than that seen in MS or NMO, although the reported frequency is highly variable ranging from 5% to 80% in case series 36–42. When the CC is involved in ADEM, there is often a high overall lesion load and lesions may be large and extend into the CC from the adjacent white matter 42. Among 12 patients with ADEM and CC involvement, the CC was involved bilaterally in all, with the splenium affected in 9 of the patients 43.…”
Lesions in the corpus callosum (CC) are important radiological clues to the diagnosis of multiple sclerosis (MS), but may also occur in other neuroinflammatory and non-neuroinflammatory conditions. In this article, we discuss the radiological features of lesions within the CC in MS and other central nervous system inflammatory and acquired demyelinating diseases. An understanding of the appearance and location of lesions in the CC is important not only for accurate diagnosis and treatment of these various conditions, but as it also provides insights into pathogenesis.
“…Other recent publications also mention relapses of DEM [22][23][24] . A curious logical hiatus occurs when changing the diagnosis from DEM to MS after a recurrence, since the MRI lesion(s) is/are still atypical and similar to those of DEM.…”
Review of the recent medical literature raises doubts about the reliability of reported prevalence rates of multiple sclerosis (MS). Many published prevalence rates are inflated. Some studies have shown that relying on clinical information and MRI interpretation leads to one third of incorrect MS diagnoses. The most important error is failing to distinguish between the clinical and MRI characteristics of MS and of disseminated encephalomyelitis (DEM) in both their acute and relapsing forms. The diagnostic criteria in current usage, including those relating to imaging, do not differentiate between MS and other recurrent inflammatory demyelinating diseases of the central nervous system. Considering a second demyelinating episode following a clinically isolated symptom or acute DEM, as confirming MS, is another major source of error. Another is including cases with onset before they entered the study group or moved to the geographic area. Neuromyelitis optica (NMO) has long been considered an MS variant and in Far Eastern countries it is counted as the ‘oriental’ form of MS, falsely inflating prevalence rates of MS in those areas. Recent immunologic and radiologic evidence shows that at least some NMO cases represent instances of DEM.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.